<DOC>
	<DOCNO>NCT02047877</DOCNO>
	<brief_summary>The purpose study two major goal : 1 ) measure amount two specific hormone interleukin ( IL ) -10 interleukin ( IL ) -12p70 mucous blood ; 2 ) compare hormone level two specific area lung call trachea ( upper airway ) bronchiole ( low airway ) . The hormones IL-10 IL-12p70 cytokine , special hormone cell use communicate inflammation infection . Cytokines measure mucous blood . The balance one cytokine compare another help doctor understand people respond differently infection . Unfortunately , amount IL-10 IL-12p70 known child , especially child lung infection . In addition , know balance cytokine differ various region lung . We believe balance IL-10 IL-12p70 similar whether measure upper low airway .</brief_summary>
	<brief_title>Airway Inflammatory Response During Illness Children With Respiratory Failure</brief_title>
	<detailed_description>This study design measure concentration describe distribution cytokine IL-10 IL-12p70 previously healthy pediatric population suffer direct lung injury infectious etiology , yet describe literature . In addition , study seek determine whether tracheal aspirate ( TA ) obtain early acute respiratory failure substitute distal airway aspirate , obtain non-bronchoscopic broncho-alevolar lavage ( nb-BAL ) , purpose investigate marker inflammation . We compare ratio IL-10 IL-12p70 time point measure tracheal secretion , bronchial secretion , blood ass sample equivalence . Finally , study affirm safety profile repeat nb-BAL , establish protocol respiratory sample collection storage future large scale study , generate feasibility data regard consent rate , estimate data completion , fraction miss data u determine whether future study involve ratio IL-10 IL-12p70 use predictor acute respiratory distress syndrome ( ARDS ) population . The data generate study regard safety , comparison nb-BAL TA , cytokine concentration use preliminary data inform design large multicenter study test hypothesis IL-10 IL-12p70 level airway secretion predict risk ARDS population . This may approach via application Pediatric Acute Lung Injury Sepsis ( PALISI ) clinical research network group .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Previously healthy Age 37 week gestation 17 year Presumed respiratory infection Intubated &lt; 48 hour Trauma , Drowning , Pancreatitis , Sepsis originate pulmonary infection . Preexisting chronic disease include : congenital heart disease acquire cardiomyopathy pulmonary hypertension restrictive lung disease cystic fibrosis asthma control chronically inhaled steroid Tracheostomy Immunocompromised include chronic steroid use within last month Oncological condition except condition active remission require maintenance chemotherapy . Intubated patient endotracheal tube &lt; 3.5 mm Patients persistent SpO2 &lt; 90 % despite adequate ventilator support , patient deem unstable undergo miniBAL clinical care team</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Respiratory Secretions</keyword>
	<keyword>Tracheal Secretions</keyword>
	<keyword>Bronchial Secretions</keyword>
	<keyword>NonBronchoscopic BAL</keyword>
	<keyword>Interleukin 10</keyword>
	<keyword>Interleukin 12p70</keyword>
</DOC>